Sentec has acquired Percussionaire, a specialty ventilation company that develops, manufactures, and markets respiratory care products, according to a company news release. The acquisition is designed to advance the company’s respiratory care offerings.
Percussionaire was founded nearly 40 years ago by the late Dr. Forrest Bird, a pioneer in respiratory care who developed flow ventilation and intrapulmonary percussive ventilation (IPV) technology.
“For us, this acquisition is a unique opportunity to build on the legacy of Dr. Bird and continue to invest in products that make a positive impact to patient care,” said Dominik Ellenrieder, chairman of Sentec, AG. “In this new era, with COVID reminding us of the importance of respiratory monitoring and therapies, we believe the Percussionaire products have an important part to play to improve patient care by enabling the least invasive interventions.”
With this acquisition, Sentec will diversify its product lines focused on respiratory monitoring to now include the Percussionaire range of products built on TRUE-IPV technology, increasing its ability to service and support respiratory care customers. Both Sentec and Percussionaire product lines play vital roles in the management of critical care patients; Bringing these products together provides the unique ability to simultaneously monitor and treat patients with varying levels of compromised respiratory function.
More information is available on Sentec’s website.
